Insider Shareholders with Direct Ownership of Artiva Biotherapeutics, Inc. (RTVA)
This section provides a comprehensive overview of the insiders with direct ownership of Artiva Biotherapeutics, Inc. (RTVA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Artiva Biotherapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 1,936,637 | 0 | 1,936,637 | 1 |
Jul 22, 2024
Added 17.71%
|
|
|
Fred Aslan
President and CEO |
1,298,041 | 75,853 | 1,209,948 | 9 |
Dec 15, 2025
Reduced 0.26%
|
|
Jennifer Bush
COO, CLO, Secy, Compliance Off |
221,527 | 11,401 | 232,925 | 6 |
Dec 12, 2025
Added 26.71%
|
| 194,108 | 0 | 194,108 | 1 |
Jul 22, 2024
Added 20.16%
|
|
|
Christopher Horan
Chief Tech Operations Officer |
192,156 | 6,817 | 185,339 | 6 |
Dec 12, 2025
Added 36.64%
|
|
Heather Raymon
SVP, Research and Development |
110,603 | 3,759 | 106,844 | 6 |
Dec 12, 2025
Added 38.63%
|
|
Neha Krishnamohan
Chief Financial Officer |
110,000 | 10,644 | 99,356 | 5 |
Nov 15, 2025
Reduced 3.39%
|
|
Thorsten Graef
Chief Medical Officer |
80,000 | 0 | 80,000 | 2 |
Feb 26, 2025
Added 42.86%
|
|
Subhashis Banerjee
Chief Medical Officer |
50,000 | 0 | 50,000 | 1 |
Apr 08, 2025
Added 50.0%
|
| 2,958,063 | 0 | 0 | 1 |
N/A
|
|